Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz (rivastigmine) is a small molecule pharmaceutical. Rivastigmine was first approved as Exelon on 1998-05-11. It is used to treat alzheimer disease in the USA. It has been approved in Europe to treat alzheimer disease, dementia, and parkinson disease. The pharmaceutical is active against acetylcholinesterase and cholinesterase.
|Trade Name||Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz|
|Indication||alzheimer disease, dementia, parkinson disease|
|Drug Class||Cholinesterase inhibitors (physostigmine type)|